Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
6
×
Tags
boston
6
×
boston blog main
boston top stories
life sciences
national blog main
national top stories
startups
6
×
biotech
new york blog main
clinical trials
deals
san francisco blog main
vc
gene therapy
investing
new york top stories
san francisco top stories
sanofi
third rock ventures
venture capital
adeno-associated virus
allosteric
alnylam pharmaceuticals
amy schulman
andreas klein
anna greka
antisense oligonucleotide
atlas venture
atopic dermatitis
autoimmune disorders
azacitidine
barry greene
benzodiazepines
beta-thalassemia
biogen
blackstone group
blackstone life sciences
brace pharma
cancer
car-t
What
medicines
6
×
drugs
new
therapeutics
years
ago
aims
gene
research
adding
address
adds
aiming
allosteric
approach
aren’t
backed
balance
based
bio
biotech
build
called
car
cause
ceo
clinic
create
crispr
cutting
debuts
decibel
developing
diagnostic
disease
diseases
edge
editing
elusive
emerged
Language
unset
Current search:
medicines
×
photo
×
boston
×
startups
×
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com
5 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”